Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent-Reference-Cited by-同舟云学术

Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent

Published:2007 Issue:1 Volume:112 Page:69-74
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kattan Michael W.,Cuzick Jack,Fisher Gabrielle,Berney Daniel M.,Oliver Tim,Foster Christopher S.,Møller Henrik,Reuter Victor,Fearn Paul,Eastham James,Scardino Peter T.,

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23106/fullpdf

Reference11 articles.

1. 20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer

2. Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

3. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

4. Radiation Therapy for Clinically Localized Prostate Cancer

5. LONG-TERM SURVIVAL PROBABILITY IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER: A CASE-CONTROL, PROPENSITY MODELING STUDY STRATIFIED BY RACE, AGE, TREATMENT AND COMORBIDITIES

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence and Pathomics;Urologic Clinics of North America;2024-02

2. Pathology Data–Based Risk Group Stratification Is Equivalent to That Obtained by Oncotype DX Testing in Prostatic Adenocarcinoma;Archives of Pathology & Laboratory Medicine;2023-01-03

3. Nomograms and scoring system for forecasting overall and cancer‐specific survival of patients with prostate cancer;Cancer Medicine;2022-08-22

4. Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+);Palliative Medicine;2021-06-15

5. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer;JAMA Network Open;2020-04-01